SST and cancer: Moreover, serum SST methylation was found to be a predictive value of cancer-specific survival in stage III patients as determined by multivariate Cox analysis (HR = 2.52, P = 0.045) but was not found to be significant in patients with stage II cancers (P = 0.08) [24].